Sotatercept Reduces Pulmonary Vascular Resistance in PAH

WEDNESDAY, March 31, 2021 -- For patients receiving background therapy for pulmonary arterial hypertension, treatment with sotatercept results in a reduction in pulmonary vascular resistance, according to a study published in the April 1 issue of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news